[PDF] Top 20 Treatment of postmenopausal osteoporosis
Has 10000 "Treatment of postmenopausal osteoporosis" found on our website. Below are the top 20 most common "Treatment of postmenopausal osteoporosis".
Treatment of postmenopausal osteoporosis
... management of osteoporosis. In view of the very low mean dietary intake of calcium in most developed and developing countries, a systematic pharmacological supplementation in ... Voir le document complet
2
Cost-effectiveness of buffered soluble alendronate 70mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
... effects of treatment on the risk of fractures (expressed as relative risks, RR) were derived from the most recent network meta-analysis of the National Institute for Health and Care Excellence ... Voir le document complet
12
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
... List of investigators: FRANCE: ...University of Louvain, Brussels; ...The Osteoporosis Research Center, Hvidovre; ...M. Osteoporosis Centre, Odense; ...Centre of Medecine, Valeggio sul ... Voir le document complet
7
Upper gastrointestinal safety and tolerability profile of once-monthly and daily oral ibandronate is similar in postmenopausal osteoporosis: 1-year results from MOBILE
... Objectives: Treatment of postmenopausal osteoporosis (PMO) with oral bisphosphonates is usually well ...incidence of upper GI AEs to placebo ...profile of once-monthly and daily ... Voir le document complet
2
Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
... Modes of Action of Agents Used in Osteoporosis Treatments for osteoporosis can be broadly divided according to their mode of ...majority of the agents act by slowing bone re- ... Voir le document complet
15
Failure in osteoporosis management after hip fracture
... these therapies is not a problem because in France, these treatments are all reimbursed by the French public health insurance agency. We believe there may be a disconnection between guidelines, orthopedic surgeons, ... Voir le document complet
30
Role of Biochemical Markers of Bone Turnover as Prognostic Indicator of Successful Osteoporosis Therapy
... course of the development of this bisphosphonate strongly support the value of BTM as a surrogate for BMD or fracture assessment in ...kers of bone resorption and formation, which eventually ... Voir le document complet
6
An Updated Systematic Review of Cost‑Effectiveness Analyses of Drugs for Osteoporosis
... year of publication, journal), study design (country, population, perspective, model type, out- come measure, time horizon, comparators, intervention duration, cost type, discount rates, year of valuation), ... Voir le document complet
29
Inhibition of bone turnover by milk intake in postmenopausal women
... None of the thirty enrolled women dropped out of the ...elevation of plasma follicle-stimulating ...level of 25-hydroxyvitamin D . 20 ng/ml. The mean value of serum PTH was within the ... Voir le document complet
9
Hormone therapy and risk of venous thromboembolism among postmenopausal women
... side-effect of postmenopausal hormone therapy. Current use of oral estrogens increases the risk of venous thromboembolism, especially during the first year of treatment, but past ... Voir le document complet
10
Do estrogens effectively prevent osteoporosis-related fractures?
... number of fractures per person-years (23 versus ...number of patients having experienced a new vertebral fracture, as recommended in regulatory guidelines [10] the difference between 7 women suffering ... Voir le document complet
4
Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec
... One of the factors contributing to low BMD testing in Canada may be the low geographical accessibility to spe- cialized BMD equipment and trained ...patterns of use of BMD in Ontario ...rate ... Voir le document complet
12
Study of risk factors, prognostic value of some biochemical, hematological and oxidative stress markers and evaluation of the effect of Proso millet on osteoporosis in postmenopausal women from Guemar (El Oued, Algeria) region
... constituents of this plant acting mainly as reducing agents or free radical terminators, metal chelating agents, hydrogen donors and singlet-oxygen quenchers during anti-oxidant mechanisms (Kim et ...type ... Voir le document complet
111
Clinical utility of a pharmacostatistical model for ibandronate in osteoporosis
... Result Content View [2004] [SAT0227] CLINICAL UTILITY OF A PHARMACOSTATISTICAL MODEL FOR IBANDRONATE IN OSTEOPOROSIS R. Gieschke 1 , J. Reginster 2 1 Pharma Development, F. Hoffmann-La Roche Ltd, Basel, ... Voir le document complet
2
Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.
... components of oste- oporosis ...action of sun- light, it is metabolized first in liver to 25-hydroxyvitamin D [25(OH)D] and then in kidney to 1,25-dihydroxyvita- min D [1,25(OH)2D], before becoming ... Voir le document complet
9
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
... and osteoporosis societies worldwide have adopted inter- vention thresholds (ITs) based on densitometric ...constellation of risk factors other than just BMD alone exist [ 13 ...offered treatment as ... Voir le document complet
12
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
... benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002, 288:321-333. 3. Utian WH, Archer DF, ... Voir le document complet
7
Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.
... among postmenopausal women [38], women with stronger estrogenic climate would be more likely to be at high thrombotic ...presence of a hyperestrogenic status rather than exclusively to the deleterious ... Voir le document complet
19
Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis.
... with osteoporosis. The SOTI (Spinal Osteoporosis Therapeutic Intervention) study was an international clinical trial comparing strontium ranelate to placebo, according to the double blind procedure, on the ... Voir le document complet
11
The osteoclast cytoskeleton – current understanding and therapeutic perspectives for osteoporosis
... organization of the osteoclast cytoskeleton. (A-B) Schematic side view of an osteoclast (A) and top view of the sealing zone ...means of a sealing zone, consisting of a belt of ... Voir le document complet
40
Sujets connexes